Family Office Real Estate Daily · Family Office Real Estate Research Desk · Preview
Research Desk
A curated index of 20,204 CRE market research reports from the major institutional publishers — filterable by asset class, market and publisher. Editorial Family-Office interpretation layer is rolling out report-by-report.
Showing Family Office Briefings with a Direct angle — each card surfaces how a family office could deploy capital in that market.
24 reports
Page 1 / 1- CBREMay 13, 2026
New York City Life Sciences Figures Q1 2026
Direct:Direct ownership of life sciences assets could provide family offices with control and customization in a rapidly growing market.
- SavillsApr 15, 2026
New York Q1 2026 Life Sciences Market Report
Direct:Direct ownership of life sciences assets may provide family offices with greater control and customization to meet specific tenant needs in this sector.
- CBREFeb 11, 2026
New York City Life Sciences Figures Q4 2025
Direct:Direct ownership of life sciences assets in New York could provide family offices with control and customization to meet specific investment goals.
- SavillsJan 14, 2026
New York Q4 2025 Life Sciences Market Report
Direct:Direct ownership of life sciences assets in New York could provide family offices with greater control and customization to meet specific tenant needs.
- CBREOct 22, 2025
New York City Life Sciences Figures Q3 2025
Direct:Direct ownership of life sciences assets in New York could provide family offices with control and customization to meet specific investment goals.
- SavillsOct 10, 2025
New York Q3 2025 Life Sciences Market Report
Direct:Direct ownership of life sciences assets could provide family offices with control and customization opportunities, particularly in a market with limited sublease options.
- CBREJul 25, 2025
New York City Life Sciences Figures Q2 2025
Direct:Direct ownership of life sciences assets in New York could provide family offices with control and customization to meet specific investment goals.
- SavillsJul 12, 2025
New York Q2 2025 Life Sciences Market Overview
Direct:Direct ownership of life sciences assets may provide family offices with greater control and customization to meet specific tenant needs.
- CBREMay 9, 2025
New York City Life Sciences Figures Q1 2025
Direct:Direct ownership of life sciences assets in New York could provide family offices with control and customization to meet specific investment goals.
- SavillsApr 11, 2025
New York Q1 2025 Life Sciences Market Overview
Direct:Direct ownership of life sciences assets in New York could provide family offices with greater control and customization to meet specific tenant needs.
- CBREMar 7, 2025
New York City Life Sciences Figures YE 2024
Direct:Direct ownership of life sciences assets in New York could offer family offices control and customization to meet specific investment goals.
- SavillsFeb 7, 2025
New York Q4 2024 Life Sciences Market Overview
Direct:Direct ownership of life sciences assets in New York could provide family offices with greater control and customization to meet specific tenant needs.
- SavillsNov 6, 2024
New York Q3 2024 Life Sciences Market Report
Direct:Direct ownership of life sciences assets may offer family offices greater control and customization to meet specific investment goals.
- CBREOct 23, 2024
New York City Life Sciences Figures Q3 2024
Direct:Direct ownership of life sciences assets in New York could offer family offices control and customization to meet specific investment goals.
- CBREAug 9, 2024
New York City Life Sciences Figures Q2 2024
Direct:Direct ownership of life sciences assets in New York could offer family offices control and customization to meet specific investment goals.
- SavillsAug 7, 2024
New York Q2 2024 Life Sciences Market Report
Direct:Direct ownership of life sciences assets could offer family offices greater control and customization to meet specific tenant needs in this competitive market.
- SavillsMay 10, 2024
New York Q1 2024 Life Sciences Market Report
Direct:Direct ownership of life sciences assets in strategic locations can provide family offices with control and customization opportunities.
- CBREApr 19, 2024
New York City Life Sciences Figures Q1 2024
Direct:Direct ownership of life sciences assets in New York could offer family offices greater control and customization to meet specific investment goals.
- CBREFeb 28, 2024
New York City Life Sciences 2023 Year End Report
Direct:Direct ownership of life sciences assets in New York could offer family offices control and customization to meet specific tenant needs.
- SavillsJan 31, 2024
New York Q4 2023 Life Sciences Market Report
Direct:Direct ownership of life sciences assets could offer family offices greater control and customization to meet specific tenant needs.
- SavillsNov 3, 2023
New York 2023 Q3 Life Sciences Market Report
Direct:Direct ownership of life sciences assets could provide family offices with control and customization options, particularly in high-demand areas close to research institutions.
- CBREOct 27, 2023
New York City Life Sciences Figures Q3 2023
Direct:Direct ownership of life sciences assets in this market allows for greater control and customization to meet specific investment strategies.
- CBREJul 12, 2023
New York City Life Sciences Figures Q2 2023
Direct:Direct ownership of life sciences assets in New York could provide family offices with greater control and customization to meet specific investment goals.
- CBREApr 25, 2023
New York City Life Sciences Figures Q1 2023
Direct:Direct ownership of life sciences assets in New York could offer family offices control and customization to meet specific investment goals.
Research Hubs
Dedicated pages for every major publisher and market — each with aggregated KPI medians, asset-class breakdowns and the latest reports, read through a family-office lens.